Semaglutide Cost Guide: What GLP-1 Therapy Really Costs
The short answer: Branded semaglutide (Wegovy and Ozempic) carries a list price around $1,000 to $1,350 per package per month, but most people never pay that. As of 2026, Novo Nordisk’s self-pay programs put cash prices closer to $349 to $499 per month, manufacturer savings cards can drop the cost to as little as $25 per month for some insured patients, and insurance coverage varies widely. Compounded semaglutide, once a cheaper workaround at $100 to $300 per month, has become legally restricted as the FDA shortage that allowed it has ended. Below is a clear breakdown of what each path actually costs and how to lower the bill.
Semaglutide is the active ingredient in three branded medications: Ozempic and Rybelsus (approved for type 2 diabetes) and Wegovy (approved for weight management). What you pay depends less on the drug itself and more on which product you get, whether insurance is involved, and which discount program you qualify for. Prices in this space change often, so treat every figure here as a current range rather than a fixed quote.
At a glance: semaglutide cost by option
| Option | Typical monthly cost (2026) | Notes |
|---|---|---|
| Branded list price (Wegovy / Ozempic) | ~$1,000 to $1,350 | Sticker price before any discount; few pay this |
| Manufacturer self-pay (NovoCare cash price) | ~$349 to $499 | For people paying cash without using insurance |
| Savings card (commercially insured) | As low as $25 | Capped monthly benefit; excludes government insurance |
| Insurance copay (when covered) | ~$25 to $100+ | Weight loss often excluded; diabetes more often covered |
| Telehealth cash programs | ~$200 to $500 | Often bundles the medication with consults |
| Compounded semaglutide | ~$100 to $300 (where still available) | Legality narrowed sharply in 2025 to 2026; see caveat below |
Branded semaglutide list prices
The published list price for Wegovy and Ozempic has historically run from roughly $1,000 to $1,350 per month’s supply, depending on the product and package. Following pricing changes in early 2026, Novo Nordisk lowered certain self-pay reference prices, with figures around $675 per month cited for some products. The important point is that the list price is a starting number, not what most patients actually hand over at the pharmacy.
Ozempic and Wegovy contain the same molecule but are priced and covered differently because they carry different approved uses. That distinction matters a great deal for insurance, which we cover next.
What insurance does and does not cover
This is where costs vary the most.
- Type 2 diabetes: When semaglutide is prescribed for diabetes (Ozempic, Rybelsus), commercial and Medicare drug plans are more likely to cover it, often leaving a copay in the $25 to $100+ range. Coverage still depends on your specific formulary and any prior authorization requirements.
- Weight management: Coverage for Wegovy prescribed purely for weight loss is far less consistent. Many commercial plans exclude anti-obesity medications entirely, and traditional Medicare has historically not covered drugs used solely for weight loss. Some employer plans add this coverage as a benefit, so it is worth checking your own plan documents directly.
Before assuming anything, call the number on your insurance card and ask two specific questions: is this drug on the formulary for my prescribed use, and does it require prior authorization? A prescription that gets denied for weight loss may be approved when there is a documented diabetes or cardiovascular indication, which is a clinical decision for your prescriber, not a billing trick.
Manufacturer savings cards and cash programs
Novo Nordisk runs savings programs that meaningfully change the math:
- Savings card (insured patients): People with commercial prescription coverage may pay as little as $25 per month, subject to a maximum monthly benefit cap. These cards generally exclude anyone on government insurance such as Medicare or Medicaid.
- Self-pay through NovoCare: For people paying cash, the manufacturer’s direct-pay pricing in 2026 has landed in the range of roughly $349 to $499 per month depending on the product and dose, with introductory pricing sometimes lower for the first fills. These offers change, and some promotional tiers have expiration dates, so confirm the current terms when you enroll.
- Patient assistance: Income-qualified patients without adequate coverage may be eligible for additional manufacturer assistance. Eligibility is specific and requires an application.
Telehealth and online pharmacy pricing
Telehealth platforms commonly advertise GLP-1 programs that bundle the prescription, clinical consults, and shipping into one monthly fee. For branded semaglutide, these programs typically reflect the manufacturer’s self-pay pricing plus the platform’s service layer, landing somewhere in the $200 to $500 per month range. Read carefully what is included. Some quotes cover only the consultation and route you to a pharmacy separately, while others bundle everything. Watch for auto-renewal terms and whether dose increases change the price.
Compounded semaglutide and the regulatory caveat
For a stretch in 2023 to 2024, compounded semaglutide was widely available at $100 to $300 per month because the branded drug was on the FDA’s official shortage list, which temporarily allowed compounding pharmacies to prepare it.
That window has largely closed. The FDA declared the semaglutide shortage resolved in early 2025 and set enforcement deadlines for compounders to wind down. By 2026 the agency moved further, proposing to keep semaglutide off the bulk compounding lists and issuing warning letters to compounding operations. The practical result:
- Large-scale (503B) production of compounded semaglutide for general distribution is no longer permitted.
- Smaller (503A) pharmacies face serious legal risk unless they can document a specific, patient-level medical need that the commercial product cannot meet, such as a documented allergy to an inactive ingredient.
- Marketing that presents compounded semaglutide as a routine cheaper substitute is a red flag. Be cautious of any seller promising easy, low-cost compounded semaglutide with no clinical justification.
If a provider offers compounded semaglutide, ask directly what legal basis applies to your situation and which licensed pharmacy is dispensing it. Honest programs can explain both. Because this area is actively in flux, verify the current FDA position before relying on a compounded product. For a fuller comparison of the molecules and how this affects choosing a medication, see our guides linked below.
HSA and FSA eligibility
Semaglutide prescribed and dispensed for an approved medical use is generally an eligible expense under a Health Savings Account or Flexible Spending Account, since it is a prescription medication. For weight management specifically, some plan administrators ask for a letter of medical necessity from your prescriber. Using pre-tax HSA or FSA dollars effectively discounts the medication by your marginal tax rate, which is one of the simpler ways to lower the real cost. Confirm the requirement with your plan administrator and keep your receipts.
How to lower what you pay
- Check your formulary first. Coverage for your specific indication is the single biggest lever. Confirm it before paying cash for anything.
- Stack the right program. If you have commercial insurance, the savings card route is usually cheapest. If you are uninsured or excluded, compare the manufacturer’s self-pay price against telehealth bundles.
- Use HSA or FSA funds for the prescription to capture the tax advantage.
- Ask about dose timing. Costs and promotions sometimes differ by dose strength and by whether you are a new or continuing patient.
- Compare pharmacies. Cash prices and discount-card prices can differ between pharmacies for the identical product.
- Reassess every few months. Pricing, coverage rules, and program terms in this category change frequently.
Frequently asked questions
Why is the list price so much higher than what people actually pay?
The list price is a published sticker number before insurance, rebates, and manufacturer discounts. Most patients pay through a savings card, a self-pay program, or an insurance copay, all of which sit well below list. The gap between list price and real cost is large for this drug class.
Is compounded semaglutide still a cheap option in 2026?
For most people, no. The FDA shortage that made widespread compounding possible has ended, and the legal pathway has narrowed sharply. Compounded semaglutide may still be available in limited, individually justified cases, but it is no longer a routine low-cost substitute, and the regulatory situation continues to shift.
Will my insurance cover semaglutide for weight loss?
Often not. Many commercial plans exclude anti-obesity medications, and traditional Medicare has generally not covered drugs used solely for weight loss. Coverage is more common when the prescription is for type 2 diabetes. Check your own plan’s formulary and prior authorization rules to be sure.
Can I use my HSA or FSA to pay for semaglutide?
Generally yes, when it is a prescription for an approved medical use. Some administrators require a letter of medical necessity for weight management. Confirm the specifics with your plan and keep documentation of the prescription and payment.
Related reading
This article is for education only and is not medical or financial advice. Drug prices, insurance coverage, savings programs, and compounding regulations change frequently and vary by individual circumstance. Verify current pricing and coverage with the manufacturer, your pharmacy, and your insurer, and consult a licensed clinician before starting, stopping, or changing any medication.
Frequently Asked Questions
How much does semaglutide cost without insurance?
The list price runs about $1,000 to $1,350 per month in 2026. If you pay cash through the manufacturer’s self-pay program (NovoCare), the cost drops to roughly $349 to $499 per month. Telehealth programs generally fall between $200 and $500 per month.
What is the difference between Ozempic, Wegovy, and Rybelsus?
All three contain semaglutide but are approved for different uses. Ozempic and Rybelsus are approved for type 2 diabetes, while Wegovy is approved for weight management. Which one applies to you affects both prescribing and how likely insurance is to cover it.
Does insurance cover semaglutide?
It depends on why it is prescribed. When used for diabetes, semaglutide is more often covered by commercial and Medicare plans. For weight loss, many commercial plans exclude anti-obesity medications, and traditional Medicare has historically not covered drugs used solely for weight loss. When it is covered, copays typically range from $25 to $100 or more per month.
How much can a manufacturer savings card reduce the price?
If you have commercial insurance, a manufacturer savings card can bring the cost down to as low as $25 per month. This is separate from the manufacturer self-pay program, which is aimed at people paying cash rather than using insurance.
Is compounded semaglutide a reliable cheaper option?
Compounded semaglutide has been priced around $100 to $300 per month, but availability is now limited. The FDA ended the semaglutide shortage in early 2025, so large-scale compounding is prohibited and smaller pharmacies face serious legal risk unless they can document patient-specific medical needs. The guide notes that marketing which presents compounded semaglutide as a routine cheaper substitute is a red flag.
Can I use an HSA or FSA to pay for semaglutide?
Yes, semaglutide qualifies as an eligible HSA or FSA expense when it is prescribed for an approved use. For weight management, some plans require a letter of medical necessity before the expense is accepted.
